Temporal Arteritis
(Giant Cell Arteritis)
Overview
Temporal arteritis,
also known as giant cell arteritis, is an inflammatory condition
affecting the medium-sized blood vessels that supply the head, eyes,
and optic nerves. The disease usually affects those over 60
years of age and causes the vessels in the temple and scalp to
become swollen and tender. Women are approximately 4 times
more likely to suffer from this disease then men.
The major concern with
temporal arteritis is vision loss, although if allowed to progress,
it may affect arteries in other areas of the body. This
condition is potentially vision threatening, however, if treated
promptly, permanent vision loss can be prevented. Vision is
threatened when the inflamed arteries obstruct blood flow to the
eyes and
optic nerves. If untreated, permanent vision loss can
occur from oxygen deprivation to the retina and optic nerve.
Signs and Symptoms
Patients with temporal
arteritis usually notice visual symptoms in one eye at first, but as
many as 50% may notice symptoms in the fellow eye within days if the
condition is untreated.
Detection and Diagnosis
When temporal
arteritis is suspected, the doctor will order blood tests
including a erythrocyte (red blood cell) sedimentation rate (ESR)
and C-reactive protein test. The ESR test measures the time it
takes for the erythrocytes to collect in the bottom of a test tube.
The sediment layer of erythrocytes is measured in millimeters and
recorded. An abnormally high ESR is indicative of active
inflammation.
C-reactive protein is
produced in the liver. This protein is released when the body
responds to an injury or any other event that signals inflammation.
C-reactive protein is measured with a blood test.
A biopsy of the
temporal artery is usually recommended. The procedure is
performed with local anesthesia. A small section of the
temporal artery is removed and examined under magnification for
inflammatory cells. This test allows doctors to definitively
diagnose temporal arteritis.
Treatment
The ophthalmologist
often works in conjunction with the patient's internist to treat
this disease. The primary treatment for the disease is oral
steroid medication to reduce the inflammatory process. Most
patients notice an improvement in their symptoms within several
days. In some cases, a long-term maintenance dosage of the
steroid is required.
St. Luke's Cataract & Laser Institute provides this on-line
information for educational and communication purposes only and it
should not be construed as personal medical advice.
Information published on this St. Luke's website is not intended to
replace, supplant, or augment a consultation with an eye care
professional regarding the viewer/user's own medical care. St.
Luke's disclaims any and all liability for injury or other damages
that could result from use of the information obtained from this
site. |